Contracts Finder

NHS National Generics Pharmaceuticals Transition 2023_1

NHS england

Awarded
goods
SME-friendly
Framework agreement

This tender has closed

The submission deadline for this contract has passed. There may be more active goods tenders from NHS england, and hundreds more across the UK public sector.

Key details

Contracting authority
Region
Runcorn
Delivery: United Kingdom
Contract value
£99,290,712ex VAT
Submissions closed
17 February 2023
Published
11 January 2023

Procurement

Contract period
1 August 2023 - 31 January 2025
1 years
Procedure type
Open procedure (above threshold)
CPV classifications
  • 33600000 Pharmaceutical products

What happened

NHS england awarded this contract to Ipca Laboratories UK Ltd | Dr.Reddy's Laboratories (UK) Limited | Relonchem Ltd | Milpharm Ltd/aurobinbdo | Sandoz Ltd | Teva UK Limited | Amarox Limited | Accord-UK Ltd | Strandhaven Ltd t/a Somex Pharma | Tillomed Laboratories ltd | Wockhardt UK Limited | Neuraxpharm UK Ltd | medac Pharma LLP | Syri Limited (T/A Thame Laboratories) | Sun Pharma UK Ltd | Crescent Pharma Ltd | Consilient Health Ltd | Day Lewis Medical Ltd | Waymade PLC | Zentiva Pharma UK Ltd | Brown & Burk UK Ltd | Aristo Pharma Limited | Eramol (UK) Ltd | Thornton and Ross Ltd | Roma Pharmaceuticals Limited | Resolution Chemicals Limited | Drugsrus Ltd | Thea Pharmaceuticals Limited | Aventis Pharma ltd t/a Sanofi | Fontus Health Ltd worth £57,604,995 on 5 May 2023. The contract runs until 31 Jan 2025.

Description

Invitation to offer for NHS National Generics Pharmaceuticals Transition 2023_1 Offer reference number: CM/PHG/22/5666 FIND A TENDER (FTS) Reference number: 2023/S 000-000801

Period of framework agreement: The total maximum duration of the framework agreement to be no more than 18 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. CM/PHG/22/5666/00 - Transition Products: CESW 01/08/2023 - 31/01/2024 (6 months) NWLN 01/08/2023 - 31/01/2025 (18 months) LSNE 01/08/2023 - 31/05/2024 (10 months)

CM/PHG/22/5666/01 - Orals (plus non-parenteral) Products: All regions: 01/08/2023 to 31/05/2024 (10 Months)

Awarded suppliers (30)

Suppliers
  • Ipca Laboratories UK Ltd
  • Dr.Reddy's Laboratories (UK) Limited
  • Relonchem Ltd
  • Milpharm Ltd/aurobinbdo
  • Sandoz Ltd
  • Teva UK Limited
  • Amarox Limited
  • Accord-UK Ltd
  • Strandhaven Ltd t/a Somex Pharma
  • Tillomed Laboratories ltd
  • Wockhardt UK Limited
  • Neuraxpharm UK Ltd
  • medac Pharma LLP
  • Syri Limited (T/A Thame Laboratories)
  • Sun Pharma UK Ltd
  • Crescent Pharma Ltd
  • Consilient Health Ltd
  • Day Lewis Medical Ltd
  • Waymade PLC
  • Zentiva Pharma UK Ltd
  • Brown & Burk UK Ltd
  • Aristo Pharma Limited
  • Eramol (UK) Ltd
  • Thornton and Ross Ltd
  • Roma Pharmaceuticals Limited
  • Resolution Chemicals Limited
  • Drugsrus Ltd
  • Thea Pharmaceuticals Limited
  • Aventis Pharma ltd t/a Sanofi
  • Fontus Health Ltd
Award value
£57,604,995
Award date
5 May 2023

Contact

Address
2nd Floor, Rutland house, Runcorn, WA7 2ES
Contact name
Sharron Giblin

Identifiers

Buyer reference
CF-1587300D0O000000rwimUAA
Notice ID
82b7505c-e6e7-47d8-bb19-a1290cc3a40d-647947
OCID
ocds-b5fd17-1b88b5ed-794a-4149-937c-9ac69f636a09

Explore related tenders

External ID: cf-ocds-b5fd17-1b88b5ed-794a-4149-937c-9ac69f636a09 • Added 4 October 2026